Envoy Medical (COCH) Free Cash Flow (2021 - 2026)

Envoy Medical has disclosed Free Cash Flow across 6 years of filings, most recently posting -$5.5 million for Q2 2026.

• In Q2 2026, Free Cash Flow fell 22.3% year-over-year to -$5.5 million; the TTM figure through Jun 2026 stood at -$21.7 million (down 32.8% YoY), while the FY2025 annual figure was -$18.4 million, up 2.9% from the prior year.
• Free Cash Flow came in at -$5.5 million for Q2 2026 at Envoy Medical, up from -$6.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.0 million in Q3 2023 to a low of -$11.2 million in Q4 2023.
• Average Free Cash Flow over 5 years is -$4.2 million, with a median of -$4.4 million recorded in 2025.
• The largest YoY upside for Free Cash Flow was 119.74% in 2023 against a maximum downside of 910.85% in 2023.
• Over 5 years, Free Cash Flow stood at -$2.4 million in 2022, then plunged by 361.4% to -$11.2 million in 2023, then soared by 59.19% to -$4.6 million in 2024, then slipped by 27.45% to -$5.8 million in 2025, then gained by 6.06% to -$5.5 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$5.5 million in Q2 2026, -$6.1 million in Q1 2026, and -$5.8 million in Q4 2025.